FST-100 in the Treatment of Acute Viral Conjunctivitis

• Status: Completed
• Trial end date: 2014-03-10
• Target enrollment: 0
• Participant gender: All

Summary

This randomized, double masked, multi-center study is being conducted to support the safety and efficacy of FST-100 for the treatment of acute viral conjunctivitis. The study intends to show superiority of FST-100 ophthalmic suspension compared to vehicle for clinical resolution of acute viral conjunctivitis.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Shire

Criteria

Inclusion Criteria:

• Have a clinical diagnosis of suspected acute viral conjunctivitis in at least one eye

Exclusion Criteria:

• Have a known sensitivity to any of the components of FST-100 or FST-100 vehicle